{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:16:49Z","timestamp":1777886209604,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ymeth.2026.02.015","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T16:26:56Z","timestamp":1772209616000},"page":"1-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Broad Screening of 2-Styrylchromones Identifies dual inhibitors of the COX-2 pathway"],"prefix":"10.1016","volume":"250","author":[{"given":"Mariana","family":"Lucas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Artur M.S.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6424-0976","authenticated-orcid":false,"given":"Eduarda","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2026.02.015_b0005","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400782","article-title":"Styrylchromones: Biological Activities and Structure-activity Relationship","volume":"20","author":"Lucas","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ymeth.2026.02.015_b0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14756360290019944","article-title":"2-Styrylchromones as novel inhibitors of xanthine oxidase. a structure-activity study","volume":"17","author":"Fernandes","year":"2002","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0015","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1016\/j.bmc.2007.06.046","article-title":"2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species","volume":"15","author":"Gomes","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0020","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/np0204038","article-title":"Marine natural products as novel antioxidant prototypes","volume":"66","author":"Takamatsu","year":"2003","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ymeth.2026.02.015_b0025","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/095632020001100604","article-title":"Synthesis and anti-rhinovirus activity of 2-styrylchromones","volume":"11","author":"Desideri","year":"2000","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ymeth.2026.02.015_b0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/095632020301400404","article-title":"Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones","volume":"14","author":"Desideri","year":"2003","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.ymeth.2026.02.015_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103285","article-title":"2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors","volume":"92","author":"Takao","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0040","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1021\/np0503808","article-title":"Neuroprotective 2-(2-phenylethyl)chromones of Imperata cylindrica","volume":"69","author":"Yoon","year":"2006","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ymeth.2026.02.015_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/436758","article-title":"Synthesis and evaluation of novel fluorinated 2-styrylchromones as antibacterial agents","volume":"2013","author":"Momin","year":"2013","journal-title":"J. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0050","first-page":"199","article-title":"Synthesis and bio-activity evaluation of 2-styrylchromones","volume":"4","author":"Ujwala","year":"2013","journal-title":"Int. J. Pharma Bio Sci."},{"key":"10.1016\/j.ymeth.2026.02.015_b0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3390\/nu14020306","article-title":"An in silico and an in vitro inhibition analysis of glycogen phosphorylase by flavonoids, styrylchromones, and pyrazoles","volume":"14","author":"Rocha","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ymeth.2026.02.015_b0060","doi-asserted-by":"crossref","DOI":"10.1007\/s00044-024-03200-8","article-title":"2-Styrylchromones as inhibitors of \u03b1-amylase and \u03b1-glucosidase enzymes for the management of type 2 diabetes mellitus","author":"Santos","year":"2024","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ymeth.2026.02.015_b0065","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1007\/s00044-012-0232-6","article-title":"Structure-activity relationship study of growth inhibitory 2-styrylchromones against carcinoma cells","volume":"22","author":"Lin","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ymeth.2026.02.015_b0070","first-page":"157","article-title":"Cytotoxic activity of styrylchromones against human tumor cell lines","volume":"19","author":"Momoi","year":"2005","journal-title":"In Vivo"},{"key":"10.1016\/j.ymeth.2026.02.015_b0075","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.ejmech.2009.01.034","article-title":"Synthesis of 2-styrylchromones as a novel class of antiproliferative agents targeting carcinoma cells","volume":"44","author":"Shaw","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0080","doi-asserted-by":"crossref","first-page":"6489","DOI":"10.21873\/anticanres.13863","article-title":"Quantitative structure\u2013cytotoxicity relationship of 2-styrylchromones","volume":"39","author":"Uesawa","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ymeth.2026.02.015_b0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2004-815488","article-title":"Secondary metabolites from marine Cyanobacteria and Algae inhibit LFA-1\/ICAM-1 mediated cell adhesion","volume":"70","author":"Takamatsu","year":"2004","journal-title":"Planta Med."},{"key":"10.1016\/j.ymeth.2026.02.015_b0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcp.2009.03.028","article-title":"Anti-inflammatory potential of 2-styrylchromones regarding their interference with arachidonic acid metabolic pathways","volume":"78","author":"Gomes","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0095","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2174\/1573406411666150209114702","article-title":"Inhibition of NF-kB activation and cytokines production in THP-1 monocytes by 2-styrylchromones","volume":"11","author":"Gomes","year":"2015","journal-title":"Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0100","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/ph15030288","article-title":"2-Styrylchromones: cytotoxicity and modulation of human neutrophils' oxidative burst","volume":"15","author":"Lucas","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ymeth.2026.02.015_b0105","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/pharmaceutics15030780","article-title":"2-Styrylchromones prevent IL-1\u03b2-Induced Pro-Inflammatory Activation of Fibroblast-like Synoviocytes while increasing COX-2 Expression","volume":"15","author":"Rufino","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ymeth.2026.02.015_b0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ymeth.2026.02.015_b0115","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4155\/ppa.12.90","article-title":"Targeting inflammation: multiple innovative ways to reduce prostaglandin E2","volume":"2","author":"Norberg","year":"2013","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.ymeth.2026.02.015_b0125","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0130","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nri3859","article-title":"Eicosanoid storm in infection and inflammation","volume":"15","author":"Dennis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","article-title":"Regulation of immune responses by prostaglandin E2","volume":"188","author":"Kalinski","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0140","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/med.21347","article-title":"Proinflammatory pathways: the modulation by flavonoids","volume":"35","author":"Ribeiro","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ymeth.2026.02.015_b0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jare.2018.03.005","article-title":"Synopsis of arachidonic acid metabolism: a review","volume":"11","author":"Hanna","year":"2018","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.ymeth.2026.02.015_b0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pharmthera.2008.01.002","article-title":"Cyclooxygenase and prostaglandin synthases in atherosclerosis: recent insights and future perspectives","volume":"118","author":"Cipollone","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymeth.2026.02.015_b0155","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(03)12841-3","article-title":"COX-3: just another COX or the solitary elusive target of paracetamol?","volume":"361","author":"Schwab","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ymeth.2026.02.015_b0160","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.835","article-title":"Pharmacological hypotheses: is acetaminophen selective in its cyclooxygenase inhibition?","volume":"9","author":"Esh","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ymeth.2026.02.015_b0165","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/187152312803476255","article-title":"Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review","volume":"11","author":"Bacchi","year":"2012","journal-title":"Anti-Inflamm. Anti-Allergy Agents Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2147\/JPR.S75160","article-title":"New insights into the use of currently available non-steroidal anti-inflammatory drugs","volume":"8","author":"Brune","year":"2015","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ymeth.2026.02.015_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105663","article-title":"Inflammation: biochemistry, cellular targets, anti-inflammatory agents and challenges with special emphasis on cyclooxygenase-2","volume":"121","author":"Kaur","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0180","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1039\/D1MD00280E","article-title":"Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors","volume":"13","author":"Ahmadi","year":"2022","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-6147(03)00077-4","article-title":"Prevention of thrombosis and vascular inflammation: benefits and limitations of selective or combined COX-1, COX-2 and 5-LOX inhibitors","volume":"24","author":"de Gaetano","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ymeth.2026.02.015_b0190","doi-asserted-by":"crossref","first-page":"30647","DOI":"10.1039\/D4RA04686B","article-title":"NSAIDs between past and present; a long journey towards an ideal COX-2 inhibitor lead","volume":"14","author":"Khalil","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.ymeth.2026.02.015_b0195","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0223-5234(01)01197-7","article-title":"Cyclooxygenase inhibitors \u2013 current status and future prospects","volume":"36","author":"Dannhardt","year":"2001","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0200","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.apsb.2022.01.002","article-title":"Recent development on COX-2 inhibitors as promising anti-inflammatory agents: the past 10 years","volume":"12","author":"Ju","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymeth.2026.02.015_b0205","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/ejoc.200900026","article-title":"Efficient syntheses of new polyhydroxylated 2,3-diaryl-9H-xanthen-9-ones","volume":"2009","author":"Santos","year":"2009","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0210","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1016\/j.bmc.2009.08.056","article-title":"Synthesis and antioxidant properties of new chromone derivatives","volume":"17","author":"Gomes","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0215","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1002\/ejoc.200300468","article-title":"Synthesis of new hydroxy-2-styrylchromones","volume":"2003","author":"Santos","year":"2003","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0220","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1016\/j.bmc.2010.05.006","article-title":"(E)-2-Styrylchromones as potential anti-norovirus agents","volume":"18","author":"Rocha-Pereira","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0225","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.bcp.2004.02.030","article-title":"Polyhydroxylated 2-styrylchromones as potent antioxidants","volume":"67","author":"Filipe","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1039\/a908539d","article-title":"A convenient synthesis of new (E)-5-hydroxy-2-styrylchromones by modifications of the Baker\u2013Venkataraman method","volume":"24","author":"Pinto","year":"2000","journal-title":"New J. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/mrc.2472","article-title":"Synthesis and structure elucidation of three series of nitro-2-styrylchromones using 1D and 2D NMR spectroscopy","volume":"47","author":"Barros","year":"2009","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0240","unstructured":"Biovision Incorporated COX-2 inhibitor screening kit (Fluorometric). https:\/\/www.biovision.com\/documentation\/datasheets\/K547.pdf (accessed 30\/12\/2021)."},{"key":"10.1016\/j.ymeth.2026.02.015_b0245","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.693","article-title":"Identification of an irreversible PPAR\u03b3 antagonist with potent anticancer activity","volume":"8","author":"Peng","year":"2020","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.ymeth.2026.02.015_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/416062","article-title":"Inhibition of heme peroxidases by melamine","volume":"2012","author":"Vanachayangkul","year":"2012","journal-title":"Enzyme Res."},{"key":"10.1016\/j.ymeth.2026.02.015_b0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1009742504152","article-title":"Assessment of cyclooxygenase inhibitors using in vitro assay systems","volume":"19","author":"Jang","year":"1997","journal-title":"Methods Cell Sci."},{"key":"10.1016\/j.ymeth.2026.02.015_b0260","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jpba.2010.08.001","article-title":"Measurement of cyclooxygenase inhibition using liquid chromatography\u2013tandem mass spectrometry","volume":"54","author":"Cao","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ymeth.2026.02.015_b0265","unstructured":"abcam Recombinant human COX1\/Cyclooxygenase 1 protein. https:\/\/www.abcam.com\/en-pt\/products\/proteins-peptides\/recombinant-human-cox1-cyclooxygenase-1-protein-ab198643#datasheet (accessed 07\/02\/2023)."},{"key":"10.1016\/j.ymeth.2026.02.015_b0270","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10753-017-0559-8","article-title":"Chlorinated flavonoids modulate the inflammatory process in human blood","volume":"40","author":"Proen\u00e7a","year":"2017","journal-title":"Inflammation"},{"key":"10.1016\/j.ymeth.2026.02.015_b0275","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1152\/japplphysiol.00424.2004","article-title":"Noninvasive in vivo monitoring of methemoglobin formation and reduction with broadband diffuse optical spectroscopy","volume":"100","author":"Lee","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103179","article-title":"New phenolic cinnamic acid derivatives as selective COX-2 inhibitors. Design, synthesis, biological activity and structure-activity relationships","volume":"91","author":"Ribeiro","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0285","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.160.3.1402","article-title":"Inflammatory agonists induce cyclooxygenase type 2 expression by human neutrophils","volume":"160","author":"Maloney","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2024.106599","article-title":"Pyrazoles have a multifaceted anti-inflammatory effect targeting prostaglandin E2, cyclooxygenases and leukocytes\u2019 oxidative burst","volume":"172","author":"Rocha","year":"2024","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0295","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10787-008-8007-x","article-title":"Human whole blood assay for rapid and routine testing of non-steroidal anti-inflammatory drugs (NSAIDs) on cyclo-oxygenase-2 activity","volume":"16","author":"Laufer","year":"2008","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ymeth.2026.02.015_b0300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.molstruc.2013.09.053","article-title":"Clinical relevance of drug binding to plasma proteins","volume":"1077","author":"Ascenzi","year":"2014","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ymeth.2026.02.015_b0305","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s10753-014-9995-x","article-title":"Flavonoids inhibit COX-1 and COX-2 enzymes and cytokine\/chemokine production in human whole blood","volume":"38","author":"Ribeiro","year":"2015","journal-title":"Inflammation"},{"key":"10.1016\/j.ymeth.2026.02.015_b0310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s13765-017-0285-9","article-title":"Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: a review","volume":"60","author":"Ranneh","year":"2017","journal-title":"Appl. Biol. Chem."},{"key":"10.1016\/j.ymeth.2026.02.015_b0315","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.fob.2015.06.001","article-title":"Reactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells","volume":"5","author":"Onodera","year":"2015","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ymeth.2026.02.015_b0320","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1367-5931(00)00130-7","article-title":"Cyclooxygenase mechanisms","volume":"4","author":"Marnett","year":"2000","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ymeth.2026.02.015_b0325","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI117842","article-title":"Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-alpha, and lipopolysaccharide","volume":"95","author":"Feng","year":"1995","journal-title":"J. Clin. Investig."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202326000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:30:01Z","timestamp":1777606201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202326000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":65,"alternative-id":["S1046202326000472"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.02.015","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Broad Screening of 2-Styrylchromones Identifies dual inhibitors of the COX-2 pathway","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2026.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}